#USA #California #Hypertension #Paradise System #Recor Medical

Innovations in Hypertension Management

World Hypertension Day, celebrated annually on May 17, serves as a critical reminder of the importance of blood pressure monitoring and management. High blood pressure, often referred to as a 'silent killer,' affects millions yet goes undiagnosed and untreated in many individuals. The theme for 2025, "Measure Your Blood Pressure Accurately, Control It, Live Longer!", emphasizes the necessity for patients to not only be aware of hypertension but also to manage it effectively.

The statistics regarding hypertension are alarming. According to a report by the World Health Organization, the number of adults diagnosed with hypertension surged from 650 million in 1990 to a staggering 1.3 billion in 2019. Disturbingly, only about 54% of these individuals are aware of their condition, and a mere 42% are receiving treatment. Misdiagnosis is common, often due to inaccurate blood pressure assessment within clinical settings. This underscores the critical need for improved monitoring and treatment methods. Hypertension can lead to severe health consequences, including heart attacks, strokes, and kidney failure, making its accurate diagnosis and treatment imperative.

A significant proportion of those treated for hypertension continue to struggle with uncontrolled blood pressure even after making lifestyle adjustments and taking multiple medications. This highlights the urgency for innovative therapies tailored for these individuals. One promising treatment is the Paradise™ Ultrasound Renal Denervation (uRDN) system developed by Recor Medical. This technology is designed to assist patients who remain unregulated and are at an increased cardiovascular risk, despite standard therapies.

The Paradise uRDN system represents a pioneering approach in hypertension therapy. It employs ultrasound technology to target sympathetic nerves surrounding the renal arteries, thus reducing their overactivity and contributing to lower blood pressure. The procedure involves the delivery of focused ultrasound energy in short bursts to denervate these nerves. Remarkably, this minimally invasive method is supported by various medical institutions, including the American Heart Association and the European Society of Cardiology.

Prof. Andrew Sharp from University College Dublin advocates for a risk-based approach to treating hypertension. He emphasizes that even modest blood pressure reductions, ranging from 5 to 10 mmHg, can significantly lower the risk of cardiovascular events, especially for patients with additional health concerns like diabetes. Early intervention in blood pressure management may also slow down vascular aging, yet it is concerning that over half of hypertensive patients do not achieve even the baseline control of 140/90 mmHg.

Current guidelines advocate for more stringent blood pressure targets, pushing for levels of 130/80 mmHg for varied patient populations. This need for advanced treatment solutions has made therapies like renal denervation particularly welcome in the medical community. The safety profile of the Paradise system is commendable, with the procedure typically taking under an hour.

Recor Medical, recognized for its advancements in hypertension treatment since 2009, has conducted several rigorous studies that validate the effectiveness and safety of the Paradise uRDN system. Their ongoing Global Paradise System Post-Approval Study aims to gather real-world evidence regarding the long-term benefits of this innovative therapy among a cohort of patients in the United States.

The Paradise uRDN is considered an adjunctive therapy for patients who have not achieved adequate blood pressure control through lifestyle changes and conventional antihypertensive medications. Qualified physicians assess candidates based on a patient's medical background. While generally safe, the procedure does carry some risks, including pain and vascular complications.

As we observe World Hypertension Day 2025, it becomes increasingly evident that innovation in hypertension treatment, such as with the Paradise system, can lead to improved outcomes for those struggling with resistant hypertension. By fostering awareness and supporting the implementation of new therapies, health professionals can facilitate a healthier future for patients grappling with this common yet serious condition.

For more information, please visit Recor Medical's official site.